Agency IQ

DECEMBER 1, 2023

Start Date End Date Event Event Type Organization 12/01/2023 12/01/2023 BIVDA Environmental Working Party Webinar/Seminar ( CLOSED ) British In Vitro Diagnostics Association (BIVDA) 12/04/2023 12/04/2023 HMA/EMA Big Data Stakeholder Forum 2023 Webinar/Seminar ( OPEN ) European Medicines Agency (EMA) / Heads of Medicines Agencies (HMA) 12/04/2023 12/04/2023 (..)

Regulations 40

Regulations Clinical Trials Production Biosimilars 40

KIF1A

MAY 4, 2024

Each week, Dr. Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. In this week’s article, researchers in Brazil identified a KIF1A mutation in a cohort of patients with congenital ataxia.

Science 116

Science Medical Schools RNA Research 116

KIF1A

MARCH 9, 2024

Dylan Verden of KIF1A.ORG summarizes newly published KIF1A-related research and highlights progress in rare disease research and therapeutic development. Ltd and was engaged in research related to the extraction and culture of stem cells and immune cells. Meet our Guest Bloggers! Having graduated from the B.S.

Laboratories 111

Laboratories Science Research Disease 111

Agency IQ

AUGUST 2, 2024

Start Date End Date Event Event Type Organization 8/5/2024 8/8/2024 PRAC August meeting Committee Meeting ( CLOSED ) Pharmacovigilance Risk Assessment Committee (PRAC) 8/6/2024 8/6/2024 Infectious Diseases Working Party Seminar ( CLOSED ) British In Vitro Diagnostics Association (BIVDA) 08/12/2024 5 weeks Explore innovative personalized therapeutic (..)

Regulations 40

Regulations Clinical Trials Production International 40

Agency IQ

JULY 8, 2024

Positive August 2024 Eurneffy (epinephrine) Ars Pharmaceuticals Irl Limited Positive August 2024 MResvia (Respiratory Syncytial Virus mRNA vaccine) Moderna Biotech Spain S.L.

Regulations 40

Regulations Pharmaceuticals Production Compliance 40

Agency IQ

OCTOBER 20, 2023

BsUFA III regulatory science pilot offers progress report, fields stakeholder criticisms and questions This week, FDA and its grantees briefed stakeholders on the status of research projects funded through the Biosimilar User Fee Act (BSUFA III) Regulatory Science Pilot Program. million (IQR: $18-36.7

Science 40

Science Biosimilars FDA Production 40

The Pharma Data

MAY 14, 2021

These Forbidden Fitness Secrets of A Modern Day Ninja Warrior are the result several decades of obsessive training and research. Ninja manuals were deliberately incomplete so the most secret knowledge was passed orally from master to apprentice. Anyway, that’s NOT what this is about. Anyway, I could go on and on.

Packaging 52

Packaging Production Vaccine International 52

Agency IQ

OCTOBER 6, 2023

BY AMANDA CONTI | OCT 4, 2023 10:40 PM CDT A quick note: How AgencyIQ gathers data on drug approvals AgencyIQ reviews drug approvals from the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). Featuring previous research by Kedest Tadesse, Kari Oakes and Alec Gaffney.

FDA 52

FDA Biosimilars Science Production 52

The Pharma Data

MAY 13, 2021

I began to research what I was missing from my exercise toolbox when it came to getting the fastest and best results for my clients. Fitness professionals work long hours and it is difficult to find the time or energy to sit down and read a textbook on exercise physiology or to look up the latest research articles.

Production 52

Production Treatment Vaccine Research 52

The Pharma Data

MAY 15, 2021

I knew I needed to take my research “off-grid”, and…. …on At an unconventional strength seminar I tracked down a bear of a man known as “The Crazy Russian”… who exposed me to weird “mental tricks” to elevating your strength simply by changing the way you THINK about how your muscles move your body…. PPCT Research Publications.

Production 52

Production Packaging Doctors Science 52